Ireland
--:--IST
Latest
Clinical Trials in Taiwan / NCT07619430
Starting soon Observational

AI-Based Wound Monitoring: Automated Wound Progression Assessment Via Marker-Free Image Sequence

NCT07619430 · tracked via the Priya Life Science Taiwan tracker
Phase
Observational
Started
2026-06-08
Last updated
2026-06-02

Condition(s) studied

Hard-to-heal WoundsAI (Artificial Intelligence)Wound CarePressure Injuries

Investigational drug(s) / intervention(s)

Marker-free wound image registration technology

Marker-free wound image registration technology: Marker-free longitudinal wound image registration and wound progression assessment using serial wound photographs.

Study summary

This study aims to develop a low-cost, marker-free intelligent wound assessment system that can analyze wound photos taken with a standard smartphone. By comparing wound images over time, the system will generate a quantifiable Wound Progression Index (WPI) to provide objective feedback on whether a wound is improving, stable, or worsening. The long-term goal is to support early detection of wound deterioration and improve wound care in both clinical and home settings.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * (1) Presence of a hard-to-heal wound that has remained unhealed for more than one month. (2)The wound can be photographed according to the standardized imaging protocol. (3)The participant was aged 18 years or older and provided informed consent personally or via a legally authorized representative, with a signed informed consent form. Exclusion Criteria: * Wounds whose margins could not be fully included within the imaging field.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
National Taiwan University Hospital Yunlin branch Douliu Yunlin

More National Taiwan University Hospital trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07619430 on ClinicalTrials.gov ↗ ← All trials in Taiwan